Form 4 for PGEN PRECIGEN, INC.
Accepted 2026-06-01 16:25:49 ET · period of report 2026-05-28 · accession 0000950103-26-008168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 16:25 | 2026-05-28 | PGEN | Sabzevari Helen | Pres, CEO | S - Sale | $4.36 | -119.2K | 3.77M | -3% | -$519.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-28 | S | D | 119,250 | $4.36 | 3,768,872 | D | — | — | (F1) Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026. |